Concentrix director granted 7,701 RSUs

Deason Jennifer reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Deason Jennifer reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Jennifer Deason received an equity award rather than buying shares on the market. She was granted 7,701 shares of common stock in the form of restricted stock units at no cash purchase price, increasing her direct holdings to 17,704 shares.

The restricted stock units were awarded under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. This is a compensation-related grant, not an open-market transaction.

Insider Trade Summary

Grant/Award: 7,701 shares

Grant/Award 1 txn

Insider Deason Jennifer

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,701	$0.00	$0.00

Holdings After Transaction: Common Stock — 17,704 shares (Direct)

Footnotes (1)

1. F1. Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Concentrix (CNXC) director Jennifer Deason report in this Form 4?

Jennifer Deason reported receiving 7,701 Concentrix common shares as restricted stock units. The award is a compensation grant under the 2020 Stock Incentive Plan, not a market purchase, and increases her direct ownership to 17,704 shares following the transaction.

Was the Concentrix (CNXC) Form 4 transaction a market buy or sell?

The Form 4 does not disclose a market buy or sell. It reports an “A” code grant, meaning Deason acquired 7,701 restricted stock units as a stock award, with no cash price per share, under the company’s 2020 Stock Incentive Plan.

How many Concentrix (CNXC) shares does Jennifer Deason hold after this award?

After the restricted stock unit grant, Deason directly holds 17,704 Concentrix common shares. This total includes the 7,701-share award reported in the filing and reflects her position immediately following the grant transaction on the reported date.

When do Jennifer Deason’s Concentrix (CNXC) restricted stock units vest?

The restricted stock units vest in full on the earlier of two dates. They vest either on the one-year anniversary of the grant date or on the date of Concentrix’s 2027 Annual Meeting of Stockholders, whichever occurs first, according to the footnote disclosure.

Under which plan were the Concentrix (CNXC) restricted stock units granted?

The restricted stock units were granted under Concentrix’s 2020 Stock Incentive Plan. This plan is used to provide equity-based compensation, and the award to director Jennifer Deason was structured as 7,701 restricted stock units with time-based vesting terms.

What does transaction code “A” mean in this Concentrix (CNXC) Form 4?

In this Form 4, transaction code “A” indicates a grant, award, or other acquisition of securities. Here, it reflects that Jennifer Deason received 7,701 restricted stock units as an equity award, not that she executed an open-market purchase of Concentrix shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 08:50 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Deason Jennifer

(Last) (First) (Middle)

39899 BALENTINE DRIVE

(Street)

NEWARK CALIFORNIA 94560

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		A(1)		7,701	A	$0	17,704	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.

Remarks:

	/s/ Andrew Farwig, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)